3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI) Sep 12, 2017 07:32AM
Albany Molecular Research (AMRI) Reports Completion of Acquisition by The Carlyle Group, GTCR Aug 31, 2017 12:31PM
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR Aug 31, 2017 12:30PM
Control4 Set to Join S&P SmallCap 600 Aug 17, 2017 05:47PM
Control4 (CTRL) Set to Join S&P SmallCap 600 Aug 17, 2017 05:18PM


Jun 29, 2017 08:11AM Albany Molecular Research (AMRI) Reports Early Termination of HSR Waiting Period for Carlyle, GTCR's Proposed Acquisition
Jun 29, 2017 08:00AM AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI
Jun 6, 2017 09:39AM Pre-Open Movers 06/06: (NIHD) (EGLT) (GIII) Higher; (HDS) (FRAN) (CONN) Lower (more...)
Jun 6, 2017 07:31AM Albany Molecular Research (AMRI) Agrees to Be Acquired by The Carlyle Group and GTCR for $21.75/Share
Jun 6, 2017 07:30AM AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash
Apr 25, 2017 04:40PM UPDATE: Albany Molecular Research (AMRI) Working with Credit Suisse to Explore Sale; Received Interest from Carlyle, Pamplona - Bloomberg